Bill Type
Congress Name
Long Title
AN ACT TO MAKE THE LAWS ON PATENTS, TRADENAMES AND TRADEMARKS MORE RESPONSIVE TO THE HEALTH CARE NEEDS OF THE FILIPINO PEOPLE BY CLARIFYING NON-PATENTABLE INVENTIONS, ALLOWING THE IMPORTATION AND EARLY DEVELOPMENT OF PATENTED MEDICINES, AND MODIFYING GOVERNMENT USE PROVISIONS FOR DRUGS AND MEDICINES, TO LOWER PRICES AND INCREASE ACCESS TO AND SUPPLY OF QUALITY DRUGS AND MEDICINES, AMENDING FOR THIS PURPOSE CERTAIN PROVISIONS OF REPUBLIC ACT NO. 8293, OTHERWISE KNOWN AS THE INTELLECTUAL PROPERTY CODE OF THE PHILIPPINES
Date filed
August 22, 2006
Scope
Legislative History
House Bill/Resolution NO. HB05718 | |
FULL TITLE : AN ACT TO MAKE THE LAWS ON PATENTS, TRADENAMES AND TRADEMARKS MORE RESPONSIVE TO THE HEALTH CARE NEEDS OF THE FILIPINO PEOPLE BY CLARIFYING NON-PATENTABLE INVENTIONS, ALLOWING THE IMPORTATION AND EARLY DEVELOPMENT OF PATENTED MEDICINES, AND MODIFYING GOVERNMENT USE PROVISIONS FOR DRUGS AND MEDICINES, TO LOWER PRICES AND INCREASE ACCESS TO AND SUPPLY OF QUALITY DRUGS AND MEDICINES, AMENDING FOR THIS PURPOSE CERTAIN PROVISIONS OF REPUBLIC ACT NO. 8293, OTHERWISE KNOWN AS THE INTELLECTUAL PROPERTY CODE OF THE PHILIPPINES | |
ABSTRACT : The bill seeks to allow the parallel importation of drugs as a tool for price reduction and introduce the Bolar provision in the Intellectual Property Code which would accelerate the production of generics. | |
PRINCIPAL AUTHOR/S : ANA THERESIA "RISA" HONTIVEROS-BARAQUEL | |
DATE FILED : 2006-08-22 | |
SIGNIFICANCE: NATIONAL | |
CO-AUTHORS : | |
1. Rosales | 2. Aguja |
CO-AUTHORS (Journal Entries) : | |
1. Nantes (019 ) | |
ACTIONS TAKEN BY THE COMMITTEE | |
MOTHER BILL: HB06035 | |
ACTIONS TAKEN BY THE COMMITTEE ON RULES | |
REFERRAL TO THE COMMITTEE ON TRADE AND INDUSTRY ON 2006-08-23 |
Abstract
The bill seeks to allow the parallel importation of drugs as a tool for price reduction and introduce the Bolar provision in the Intellectual Property Code which would accelerate the production of generics.'
Disclaimer
Note: Legislative history and other information accessed from Congress Legis. Information as of April 20, 2022.